Literature DB >> 25367575

Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Mizuho Hasegawa1, Shoko Yada2, Meng Zhen Liu1, Nobuhiko Kamada3, Raúl Muñoz-Planillo4, Nhu Do1, Gabriel Núñez4, Naohiro Inohara5.   

Abstract

Pathobionts play a critical role in disease development, but the immune mechanisms against pathobionts remain poorly understood. Here, we report a critical role for interleukin-22 (IL-22) in systemic protection against bacterial pathobionts that translocate into the circulation after infection with the pathogen Clostridium difficile. Infection with C. difficile induced IL-22, and infected Il22(-/-) mice harbored high numbers of pathobionts in extraintestinal organs despite comparable pathogen load and intestinal damage in mutant and wild-type mice. Pathobionts exhibited increased resistant against complement-mediated phagocytosis, and their intravenous administration resulted in high animal mortality. Selective removal of translocated commensals rescued Il22(-/-) mice, and IL-22 administration enhanced the elimination of pathobionts. Mechanistically, IL-22 augmented bacterial phagocytosis by increasing the expression and bacterial binding of complement C3. Our study demonstrates an unexpected role for IL-22 in controlling the elimination of pathobionts that enter the systemic circulation through the regulation of the complement system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367575      PMCID: PMC4220303          DOI: 10.1016/j.immuni.2014.09.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  40 in total

1.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.

Authors:  Shean J Aujla; Yvonne R Chan; Mingquan Zheng; Mingjian Fei; David J Askew; Derek A Pociask; Todd A Reinhart; Florencia McAllister; Jennifer Edeal; Kristi Gaus; Shahid Husain; James L Kreindler; Patricia J Dubin; Joseph M Pilewski; Mike M Myerburg; Carol A Mason; Yoichiro Iwakura; Jay K Kolls
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

Review 2.  Overview of severe Clostridium difficile infection.

Authors:  Stephen R Eaton; John E Mazuski
Journal:  Crit Care Clin       Date:  2013-08-06       Impact factor: 3.598

3.  The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria.

Authors:  Judith Behnsen; Stefan Jellbauer; Christina P Wong; Robert A Edwards; Michael D George; Wenjun Ouyang; Manuela Raffatellu
Journal:  Immunity       Date:  2014-02-06       Impact factor: 31.745

Review 4.  Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs.

Authors:  Mark J Koenigsknecht; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

5.  Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17.

Authors:  Silke M Schulz; Gabriele Köhler; Nicole Schütze; Jens Knauer; Reinhard K Straubinger; Alissa A Chackerian; Ellen Witte; Kerstin Wolk; Robert Sabat; Yoichiro Iwakura; Christoph Holscher; Uwe Müller; Robert A Kastelein; Gottfried Alber
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

6.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

Review 7.  Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers.

Authors:  Andrea Lo Vecchio; Mitchell B Cohen
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

8.  Plasma Proteome Database as a resource for proteomics research: 2014 update.

Authors:  Vishalakshi Nanjappa; Joji Kurian Thomas; Arivusudar Marimuthu; Babylakshmi Muthusamy; Aneesha Radhakrishnan; Rakesh Sharma; Aafaque Ahmad Khan; Lavanya Balakrishnan; Nandini A Sahasrabuddhe; Satwant Kumar; Binit Nitinbhai Jhaveri; Kaushal Vinaykumar Sheth; Ramesh Kumar Khatana; Patrick G Shaw; Srinivas Manda Srikanth; Premendu P Mathur; Subramanian Shankar; Dindagur Nagaraja; Rita Christopher; Suresh Mathivanan; Rajesh Raju; Ravi Sirdeshmukh; Aditi Chatterjee; Richard J Simpson; H C Harsha; Akhilesh Pandey; T S Keshava Prasad
Journal:  Nucleic Acids Res       Date:  2013-12-03       Impact factor: 16.971

Review 9.  Emerging insights on intestinal dysbiosis during bacterial infections.

Authors:  Tu Anh N Pham; Trevor D Lawley
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

Review 10.  Overview of complement activation and regulation.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

View more
  77 in total

Review 1.  Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

Authors:  Alyse L Frisbee; William A Petri
Journal:  Trends Mol Med       Date:  2020-02-17       Impact factor: 11.951

2.  Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity.

Authors:  Cristiane Sécca; Jennifer K Bando; José L Fachi; Susan Gilfillan; Vincent Peng; Blanda Di Luccia; Marina Cella; Keely G McDonald; Rodney D Newberry; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

Review 3.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

4.  Safety profile after prolonged C3 inhibition.

Authors:  Edimara S Reis; Nadja Berger; Xin Wang; Sophia Koutsogiannaki; Robert K Doot; Justin T Gumas; Periklis G Foukas; Ranillo R G Resuello; Joel V Tuplano; David Kukis; Alice F Tarantal; Anthony J Young; Tetsuhiro Kajikawa; Athena M Soulika; Dimitrios C Mastellos; Despina Yancopoulou; Ali-Reza Biglarnia; Markus Huber-Lang; George Hajishengallis; Bo Nilsson; John D Lambris
Journal:  Clin Immunol       Date:  2018-10-10       Impact factor: 3.969

5.  Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection.

Authors:  Michael C Abt; Brittany B Lewis; Silvia Caballero; Huizhong Xiong; Rebecca A Carter; Bože Sušac; Lilan Ling; Ingrid Leiner; Eric G Pamer
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

6.  Infectious disease: IL-22 complements protection.

Authors:  Elisabeth Kugelberg
Journal:  Nat Rev Immunol       Date:  2014-10-31       Impact factor: 53.106

7.  Interleukin-22 Prevents Microbial Dysbiosis and Promotes Intestinal Barrier Regeneration Following Acute Injury.

Authors:  Adam M Hammer; Niya L Morris; Abigail R Cannon; Omair M Khan; Robin C Gagnon; Nellie V Movtchan; Ilse van Langeveld; Xiaoling Li; Bin Gao; Mashkoor A Choudhry
Journal:  Shock       Date:  2017-12       Impact factor: 3.454

Review 8.  Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.

Authors:  Louis J Cohen; Judy H Cho; Dirk Gevers; Hiutung Chu
Journal:  Gastroenterology       Date:  2019-03-14       Impact factor: 22.682

Review 9.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

Review 10.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.